BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Avantor® Reports Third Quarter 2025 Results

  October 29, 2025

   · 

  22 min read
• Press Releases

  Kyverna Therapeutics Announces Positive Interim Phase 2 Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025

  October 29, 2025

   · 

  10 min read
• Press Releases

  United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results

  October 29, 2025

   · 

  11 min read
• Press Releases

  Lung Association Steps Up with $22 Million in Research Funding as Federal Support for Science Wavers

  October 29, 2025

   · 

  4 min read
• Press Releases

  Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution

  October 29, 2025

   · 

  13 min read
• Press Releases

  Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032

  October 29, 2025

   · 

  5 min read
• Press Releases

  CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS

  October 29, 2025

   · 

  32 min read
• Press Releases

  Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients

  October 29, 2025

   · 

  6 min read
• Press Releases

  Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability

  October 29, 2025

   · 

  5 min read
• Press Releases

  Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards

  October 29, 2025

   · 

  4 min read